MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Cerebrospinal α-synuclein RT-QuIC in pathologically-confirmed Multiple System Atrophy

    A. Symonds, G. Fairfoul, A. Green, D. Breen (Edinburgh, United Kingdom)

    Objective: To assess the sensitivity of CSF α-synuclein RT-QuIC in pathologically-confirmed MSA. Background: Multiple system atrophy (MSA) is a rare neurodegenerative disorder characterised pathologically by…
  • 2022 International Congress

    Distinct Patterns of Tremor Network Microstructure for Essential Tremor and Parkinson’s Disease

    T. Welton, A. Ong, S. Hartono, Y-C. Shih, A. Lee, E-K. Tan, L-L. Chan (Singapore, Singapore)

    Objective: We aimed to identify differential patterns of aberrant tremor network microstructure using DSI among the following groups: (1) ET, (2) PD, and (3) healthy…
  • 2022 International Congress

    Postural tremors due to a cystic thalamic low-grade glioma treated by stereotactic aspiration

    M. Agrawal, S. Bhaskar, A. Arora, S. Panda, M. Garg, D. Jha (Jodhpur, India)

    Objective: To describe a rare case of contralateral postural tremors of the upper extremity as the only presenting complaint due to a thalamic solid cystic…
  • 2022 International Congress

    Delayed Osmotic Demyelination Syndrome- An Evolving Spectrum

    S. Garg, K. Shetty (Bengaluru, India)

    Objective: To report a case of osmotic demyelination syndrome (ODS) with continuing clinical and radiological worsening beyond its previously established temporal course. Background: ODS is…
  • 2022 International Congress

    Progress of the UK Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial

    A. Bamford, S. Neumann, J. Taylor, G. Young, S. Emmett, W. Hollingworth, A. Whone, D. Steeds, C. Metcalfe, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: This abstract provides an overview of the progress of the CHIEF-PD trial. Background: Falls are a common and debilitating consequence of Parkinson’s disease (PD).…
  • 2022 International Congress

    Electrophysiological correlates of neurological deficits in toxic-metabolic encephalopathy

    N. Prezelj, K. Vogelnik, B. štabuc, M. Kojovic (Ljubljana, Slovenia)

    Objective: We used transcranial magnetic stimulation (TMS) paradigms reflecting GABAA, GABAB, cholinergic and glutamatergic transmission at the motor cortex level, to investigate pathophysiology of different…
  • 2022 International Congress

    Heart-brain synchronization breakdown in Parkinson’s disease

    M. Iniguez, A. Jimenez-Marin, A. Erramuzpe, M. Acera, B. Tijero, A. Murueta-Goyena, R. Del Pino, T. Fernandez, M. Carmona‑abellan, A. Cabrera, JC. Gomez‑esteban, J. Cortes, I. Gabilondo (Getafe, Spain)

    Objective: To evaluate the alterations in the synchronization between central autonomic network (CAN) activity and a broad set of heart rate variability (HRV) parameters reflecting…
  • 2022 International Congress

    Gait analysis using Wearable Sensors: different gait metrics can differentiate Parkinson’s Disease Patients from Healthy Controls and Parkinson’s Disease patients in different medication status

    R. Barbosa, M. Medonça, R. Oliveira, M. Santos, A. Abreu, P. Bastos, P. Pita-Lobo, A. Valadas, L. Correia-Guedes, J. Ferreira, M. Rosa, R. Matias, M. Coelho (Lisbon, Portugal)

    Objective: To identify which gait metrics better distinguish PD-OFF from PD Best-ON and PD from HC, using a dimensionality-reduction method Background: Objective gait analysis using…
  • 2022 International Congress

    A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III

    D. Trundell, L. Barrett, R. Rogers, E. Davies, S. Zanigni, N. Pross, G. Pagano, T. Nikolcheva, S. Cano (Welwyn Garden City, United Kingdom)

    Objective: To establish a threshold for meaningful progression on MDS-UPDRS Part III in an early-stage Parkinson's disease (PD) population (Hoehn & Yahr [H&Y] Stage I–II)…
  • 2022 International Congress

    MIBG uptakes in the major salivary glands among Lewy body disease using a semi-automatic quantitative method

    J. Ebina, S. Mizumura, N. Ishii, Y. Kobayashi, M. Shibukawa, J. Nagasawa, M. Yanagihashi, T. Hirayama, K. Kawabe, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: The purpose of the study is to analyze 123I-metaiodobenzhylguanidine (MIBG) uptakes in the submandibular and parotid glands in patient with Lewy body disease (LBD)…
  • « Previous Page
  • 1
  • …
  • 776
  • 777
  • 778
  • 779
  • 780
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley